NOS+SARS-CoV-2 Pathogenesis Roman Gurinovich Yuliya Buinitskaya 10.6084/m9.figshare.12034962.v1 https://figshare.com/articles/preprint/NOS_SARS-CoV-2_Pathogenesis/12034962 <div> <div> <div> <div> <p>COVID-19 aggravates already compromised NO production in cohort with NOS3 polymorphism. Management of eNOS/iNOS ratio and NO level can prevent development of severe ARDS. </p> </div> </div> </div> </div> 2020-03-26 17:24:47 SARS-CoV-2 covid-19 nitric oxide polymorphism ARDS italian NOS Clinical Microbiology Clinical Pharmacology and Therapeutics Diseases Intensive Care Medical Virology Molecular Targets